EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,511,385 | -5.7% | 1,440,724 | +2.7% | 0.00% | – |
Q2 2023 | $12,208,171 | +196.8% | 1,403,238 | +0.3% | 0.00% | – |
Q1 2023 | $4,113,157 | -15.8% | 1,399,033 | +0.2% | 0.00% | – |
Q4 2022 | $4,884,552 | -55.8% | 1,395,586 | -0.2% | 0.00% | – |
Q3 2022 | $11,061,000 | +3.7% | 1,398,488 | +3.2% | 0.00% | – |
Q2 2022 | $10,666,000 | -28.8% | 1,355,318 | +9.9% | 0.00% | – |
Q1 2022 | $14,979,000 | +2.9% | 1,232,801 | +3.7% | 0.00% | – |
Q4 2021 | $14,553,000 | +27.9% | 1,188,970 | +8.8% | 0.00% | – |
Q3 2021 | $11,382,000 | +16.5% | 1,092,306 | +0.6% | 0.00% | – |
Q2 2021 | $9,766,000 | +6.3% | 1,086,329 | +20.1% | 0.00% | – |
Q1 2021 | $9,190,000 | +334.1% | 904,439 | +181.1% | 0.00% | – |
Q4 2020 | $2,117,000 | – | 321,703 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |